February 16, 2016 Quiet period prior to the annual report begins
March 2, 2016 Deadline for shareholder proposals for the AGM
March 16, 2016 Annual report for 2015
April 14, 2016 Annual General Meeting
April 20, 2016 Quiet period prior to the Interim report begins
May 4, 2016 Interim report - 3 months 2016
July 21, 2016 Quiet period prior to the Interim report begins
August 4, 2016 Interim report - 6 months 2016
October 20, 2016 Quiet period prior to the Interim report begins
November 3, 2016 Interim report - 9 months 2016
Further information:
Christina Thomsen, Investor Relations Manager
Tel. no. (+45) 45 29 00 00, e-mail investor@bioporto.com
About BioPorto
BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. Our pioneering product portfolio includes assays for underserved disease states such as NGAL for acute kidney injury. We sell our products in more than 80 countries through diverse sales channels and partners. BioPorto has its headquarters in Copenhagen, Denmark and is listed on the Nasdaq Copenhagen stock exchange.
